Go offline with the Player FM app!
In Conversation With… Prasad Kulkarni on a dengue monoclonal antibody
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on September 18, 2025 15:32 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 402616983 series 2902414
Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development.
122 episodes
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on September 18, 2025 15:32 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 402616983 series 2902414
Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development.
122 episodes
सभी एपिसोड
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.